{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:34:45Z","timestamp":1784975685154,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372546"],"award-info":[{"award-number":["81372546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670199"],"award-info":[{"award-number":["81670199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12964-018-0280-8","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T13:09:10Z","timestamp":1539695350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["TRPV2-induced Ca2+-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma"],"prefix":"10.1186","volume":"16","author":[{"given":"Hua","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiupan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juejin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6497-1194","authenticated-orcid":false,"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"280_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"280_CR2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"280_CR3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","volume":"17","author":"N Raje","year":"2011","unstructured":"Raje N, Roodman GD. Advances in the biology and treatment of bone disease in multiple myeloma. Clin Cancer Res. 2011;17:1278\u201386.","journal-title":"Clin Cancer Res"},{"key":"280_CR4","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.hoc.2007.08.009","volume":"21","author":"S Lentzsch","year":"2007","unstructured":"Lentzsch S, Ehrlich LA, Roodman GD. Pathophysiology of multiple myeloma bone disease. Hematol Oncol Clin North Am. 2007;21:1035\u201349 viii.","journal-title":"Hematol Oncol Clin North Am"},{"key":"280_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1681\/ASN.V22191","volume":"2","author":"KR Tuttle","year":"1991","unstructured":"Tuttle KR, Kunau RT, Loveridge N, Mundy GR. Altered renal calcium handling in hypercalcemia of malignancy. J Am Soc Nephrol. 1991;2:191\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"280_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655\u201364.","journal-title":"N Engl J Med"},{"issue":"1","key":"280_CR7","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar2168","volume":"9","author":"BO Oyajobi","year":"2007","unstructured":"Oyajobi BO. Multiple myeloma\/hypercalcemia. Arthritis Res Ther. 2007;9(1):S4.","journal-title":"Arthritis Res Ther"},{"key":"280_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0014-4827(88)90191-7","volume":"175","author":"IA Silver","year":"1988","unstructured":"Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988;175:266\u201376.","journal-title":"Exp Cell Res"},{"key":"280_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/27094","volume":"395","author":"MJ Berridge","year":"1998","unstructured":"Berridge MJ, Bootman MD, Lipp P. Calcium--a life and death signal. Nature. 1998;395:645\u20138.","journal-title":"Nature"},{"key":"280_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm1155","volume":"4","author":"MJ Berridge","year":"2003","unstructured":"Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4:517\u201329.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"280_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1124\/mol.105.021154","volume":"69","author":"R Takezawa","year":"2006","unstructured":"Takezawa R, Cheng H, Beck A, Ishikawa J, Launay P, Kubota H, Kinet JP, Fleig A, Yamada T, Penner R. A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol. 2006;69:1413\u201320.","journal-title":"Mol Pharmacol"},{"key":"280_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-4598-13-42","volume":"13","author":"E Joeckel","year":"2014","unstructured":"Joeckel E, Haber T, Prawitt D, Junker K, Hampel C, Thuroff JW, Roos FC, Brenner W. High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor. Mol Cancer. 2014;13:42.","journal-title":"Mol Cancer"},{"key":"280_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3:889\u2013901.","journal-title":"Dev Cell"},{"key":"280_CR14","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1002\/ijc.28591","volume":"134","author":"MB Morelli","year":"2014","unstructured":"Morelli MB, Offidani M, Alesiani F, Discepoli G, Liberati S, Olivieri A, Santoni M, Santoni G, Leoni P, Nabissi M. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2. Int J Cancer. 2014;134:2534\u201346.","journal-title":"Int J Cancer"},{"key":"280_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature02196","volume":"426","author":"DE Clapham","year":"2003","unstructured":"Clapham DE. TRP channels as cellular sensors. Nature. 2003;426:517\u201324.","journal-title":"Nature"},{"key":"280_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/nau.20511","volume":"27","author":"W Everaerts","year":"2008","unstructured":"Everaerts W, Gevaert T, Nilius B, De Ridder D. On the origin of bladder sensing: Tr(i)ps in urology. Neurourol Urodyn. 2008;27:264\u201373.","journal-title":"Neurourol Urodyn"},{"key":"280_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/gcc.20494","volume":"46","author":"S Fabris","year":"2007","unstructured":"Fabris S, Todoerti K, Mosca L, Agnelli L, Intini D, Lionetti M, Guerneri S, Lambertenghi-Deliliers G, Bertoni F, Neri A. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma. Genes Chromosomes Cancer. 2007;46:1109\u201318.","journal-title":"Genes Chromosomes Cancer"},{"key":"280_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/187446720603140415215431","volume":"6","author":"MB Morelli","year":"2013","unstructured":"Morelli MB, Liberati S, Amantini C, Nabiss M, Santoni M, Farfariello V, Santoni G. Expression and function of the transient receptor potential ion channel family in the hematologic malignancies. Curr Mol Pharmacol. 2013;6:137\u201348.","journal-title":"Curr Mol Pharmacol"},{"key":"280_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.1665","volume":"28","author":"L Shi","year":"2010","unstructured":"Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, et al. The MicroArray quality control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol. 2010;28:827\u201338.","journal-title":"Nat Biotechnol"},{"key":"280_CR20","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Burington B, et al. The molecular classification of multiple myeloma. Blood. 2006;108:2020\u20138.","journal-title":"Blood"},{"key":"280_CR21","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/leu.2017.115","volume":"31","author":"M Hao","year":"2017","unstructured":"Hao M, Franqui-Machin R, Xu H, Shaughnessy J Jr, Barlogie B, Roodman D, Quelle DE, Janz S, Tomasson MH, Sanderson RD, et al. NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. Leukemia. 2017;31:1648\u201350.","journal-title":"Leukemia"},{"key":"280_CR22","doi-asserted-by":"publisher","first-page":"13772","DOI":"10.18632\/oncotarget.3830","volume":"6","author":"L Raimondi","year":"2015","unstructured":"Raimondi L, De Luca A, Amodio N, Manno M, Raccosta S, Taverna S, Bellavia D, Naselli F, Fontana S, Schillaci O, et al. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget. 2015;6:13772\u201389.","journal-title":"Oncotarget"},{"key":"280_CR23","doi-asserted-by":"publisher","unstructured":"Peng Q, Luo A, Zhou Z, Xuan W, Qiu M, Wu Q, Xu L, Kong X, Zhang M, Tan W, et al. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-kappaB and NFATc1. Cytokine. 2018. https:\/\/doi.org\/10.1016\/j.cyto.2018.06.032 .","DOI":"10.1016\/j.cyto.2018.06.032"},{"key":"280_CR24","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/SHK.0b013e3181cc0738","volume":"33","author":"CR Yang","year":"2010","unstructured":"Yang CR, Lai CC. Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1. Shock. 2010;33:662\u20137.","journal-title":"Shock"},{"key":"280_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0006-291X(02)02690-6","volume":"299","author":"T Yamaguchi","year":"2002","unstructured":"Yamaguchi T, Yamauchi M, Sugimoto T, Chauhan D, Anderson KC, Brown EM, Chihara K. The extracellular calcium Ca2+o-sensing receptor is expressed in myeloma cells and modulates cell proliferation. Biochem Biophys Res Commun. 2002;299:532\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"280_CR26","doi-asserted-by":"publisher","first-page":"832127","DOI":"10.1155\/2015\/832127","volume":"2015","author":"DS Amarasekara","year":"2015","unstructured":"Amarasekara DS, Yu J, Rho J. Bone loss triggered by the cytokine network in inflammatory autoimmune diseases. J Immunol Res. 2015;2015:832127.","journal-title":"J Immunol Res"},{"key":"280_CR27","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.21821","volume":"54","author":"JR Edwards","year":"2006","unstructured":"Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, Sabokbar A. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum. 2006;54:1451\u201362.","journal-title":"Arthritis Rheum"},{"key":"280_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/leu.2008.336","volume":"23","author":"GD Roodman","year":"2009","unstructured":"Roodman GD. Pathogenesis of myeloma bone disease. Leukemia. 2009;23:435\u201341.","journal-title":"Leukemia"},{"key":"280_CR29","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1182\/blood-2002-01-0148","volume":"99","author":"O Sezer","year":"2002","unstructured":"Sezer O, Heider U, Jakob C, Zavrski I, Eucker J, Possinger K, Sers C, Krenn V. Immunocytochemistry reveals RANKL expression of myeloma cells. Blood. 2002;99:4646\u20137 author reply 4647.","journal-title":"Blood"},{"key":"280_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bone.2011.04.006","volume":"49","author":"HL Lee","year":"2011","unstructured":"Lee HL, Bae OY, Baek KH, Kwon A, Hwang HR, Qadir AS, Park HJ, Woo KM, Ryoo HM, Baek JH. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-kappaB ligand in osteoblasts. Bone. 2011;49:242\u20139.","journal-title":"Bone"},{"key":"280_CR31","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.4049\/jimmunol.162.8.4755","volume":"162","author":"J Liu","year":"1999","unstructured":"Liu J, Masuda ES, Tsuruta L, Arai N, Arai K. Two independent calcineurin-binding regions in the N-terminal domain of murine NF-ATx1 recruit calcineurin to murine NF-ATx1. J Immunol. 1999;162:4755\u201361.","journal-title":"J Immunol"},{"key":"280_CR32","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1073\/pnas.97.13.7130","volume":"97","author":"S Park","year":"2000","unstructured":"Park S, Uesugi M, Verdine GL. A second calcineurin binding site on the NFAT regulatory domain. Proc Natl Acad Sci U S A. 2000;97:7130\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"280_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10616-009-9200-5","volume":"59","author":"X Wu","year":"2009","unstructured":"Wu X, Lin M, Li Y, Zhao X, Yan F. Effects of DMEM and RPMI 1640 on the biological behavior of dog periosteum-derived cells. Cytotechnology. 2009;59:103\u201311.","journal-title":"Cytotechnology"},{"key":"280_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1124\/mol.107.037044","volume":"72","author":"V Juvin","year":"2007","unstructured":"Juvin V, Penna A, Chemin J, Lin YL, Rassendren FA. Pharmacological characterization and molecular determinants of the activation of transient receptor potential V2 channel orthologs by 2-aminoethoxydiphenyl borate. Mol Pharmacol. 2007;72:1258\u201368.","journal-title":"Mol Pharmacol"},{"key":"280_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/17474086.2017.1283213","volume":"10","author":"M Gavriatopoulou","year":"2017","unstructured":"Gavriatopoulou M, Dimopoulos MA, Kastritis E, Terpos E. Emerging treatment approaches for myeloma-related bone disease. Expert Rev Hematol. 2017;10:217\u201328.","journal-title":"Expert Rev Hematol"},{"key":"280_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-3-319-40320-5_14","volume":"169","author":"H Eda","year":"2016","unstructured":"Eda H, Santo L, David Roodman G, Raje N. Bone disease in multiple myeloma. Cancer Treat Res. 2016;169:251\u201370.","journal-title":"Cancer Treat Res"},{"key":"280_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00774-009-0154-7","volume":"28","author":"GD Roodman","year":"2010","unstructured":"Roodman GD. Targeting the bone microenvironment in multiple myeloma. J Bone Miner Metab. 2010;28:244\u201350.","journal-title":"J Bone Miner Metab"},{"key":"280_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2141.2009.07980.x","volume":"148","author":"TL Andersen","year":"2010","unstructured":"Andersen TL, Soe K, Sondergaard TE, Plesner T, Delaisse JM. Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells. Br J Haematol. 2010;148:551\u201361.","journal-title":"Br J Haematol"},{"key":"280_CR39","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3892\/etm.2013.1301","volume":"6","author":"Q Liu","year":"2013","unstructured":"Liu Q, Wang X. Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells. Exp Ther Med. 2013;6:1277\u201382.","journal-title":"Exp Ther Med"},{"key":"280_CR40","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.bbadis.2007.05.006","volume":"1772","author":"N Prevarskaya","year":"2007","unstructured":"Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. Biochim Biophys Acta. 2007;1772:937\u201346.","journal-title":"Biochim Biophys Acta"},{"key":"280_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.20050978","volume":"202","author":"N Kim","year":"2005","unstructured":"Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med. 2005;202:589\u201395.","journal-title":"J Exp Med"},{"key":"280_CR42","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1365-2141.1999.01193.x","volume":"104","author":"HI Sati","year":"1999","unstructured":"Sati HI, Greaves M, Apperley JF, Russell RG, Croucher PI. Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma. Br J Haematol. 1999;104:350\u20137.","journal-title":"Br J Haematol"},{"key":"280_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","volume":"20","author":"T Suda","year":"1999","unstructured":"Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999;20:345\u201357.","journal-title":"Endocr Rev"},{"key":"280_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007;40:251\u201364.","journal-title":"Bone"},{"key":"280_CR45","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1359\/jbmr.2000.15.8.1459","volume":"15","author":"JM Quinn","year":"2000","unstructured":"Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res. 2000;15:1459\u201366.","journal-title":"J Bone Miner Res"},{"key":"280_CR46","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.4049\/jimmunol.173.8.4838","volume":"173","author":"H Kitaura","year":"2004","unstructured":"Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol. 2004;173:4838\u201346.","journal-title":"J Immunol"},{"key":"280_CR47","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1210\/endo.141.12.7852","volume":"141","author":"M Takami","year":"2000","unstructured":"Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Endocrinology. 2000;141:4711\u20139.","journal-title":"Endocrinology"},{"key":"280_CR48","first-page":"5438","volume":"63","author":"AN Farrugia","year":"2003","unstructured":"Farrugia AN, Atkins GJ, To LB, Pan B, Horvath N, Kostakis P, Findlay DM, Bardy P, Zannettino AC. Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Res. 2003;63:5438\u201345.","journal-title":"Cancer Res"},{"key":"280_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","volume":"10","author":"MM Winslow","year":"2006","unstructured":"Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR. Calcineurin\/NFAT signaling in osteoblasts regulates bone mass. Dev Cell. 2006;10:771\u201382.","journal-title":"Dev Cell"},{"key":"280_CR50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ceca.2010.09.010","volume":"48","author":"H Kajiya","year":"2010","unstructured":"Kajiya H, Okamoto F, Nemoto T, Kimachi K, Toh-Goto K, Nakayana S, Okabe K. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations. Cell Calcium. 2010;48:260\u20139.","journal-title":"Cell Calcium"},{"key":"280_CR51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1632","volume":"5","author":"F Macian","year":"2005","unstructured":"Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005;5:472\u201384.","journal-title":"Nat Rev Immunol"},{"key":"280_CR52","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/jcp.24858","volume":"230","author":"J Yao","year":"2015","unstructured":"Yao J, Li J, Zhou L, Cheng J, Chim SM, Zhang G, Quinn JM, Tickner J, Zhao J, Xu J. Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-kappaB and NFAT activity. J Cell Physiol. 2015;230:1235\u201342.","journal-title":"J Cell Physiol"},{"key":"280_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/aps.2015.85","volume":"37","author":"XZ Zeng","year":"2016","unstructured":"Zeng XZ, He LG, Wang S, Wang K, Zhang YY, Tao L, Li XJ, Liu SW. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-kappaB and NFATc1 activation and DC-STAMP expression. Acta Pharmacol Sin. 2016;37:255\u201363.","journal-title":"Acta Pharmacol Sin"},{"key":"280_CR54","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00424-016-1846-1","volume":"468","author":"W Sun","year":"2016","unstructured":"Sun W, Uchida K, Takahashi N, Iwata Y, Wakabayashi S, Goto T, Kawada T, Tominaga M. Activation of TRPV2 negatively regulates the differentiation of mouse brown adipocytes. Pflugers Arch. 2016;468:1527\u201340.","journal-title":"Pflugers Arch"},{"key":"280_CR55","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","volume":"109","author":"F Zhan","year":"2007","unstructured":"Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Zangari M, et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood. 2007;109:1692\u2013700.","journal-title":"Blood"},{"key":"280_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/gcc.20404","volume":"46","author":"L Lombardi","year":"2007","unstructured":"Lombardi L, Poretti G, Mattioli M, Fabris S, Agnelli L, Bicciato S, Kwee I, Rinaldi A, Ronchetti D, Verdelli D, et al. Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease. Genes Chromosomes Cancer. 2007;46:226\u201338.","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-018-0280-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T01:35:06Z","timestamp":1693964106000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-018-0280-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1186\/s12964-018-0280-8","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"13 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clinical data was collected from the First Affiliated Hospital of Nanjing Medical University, written informed consent was obtained from all of the patients. The study was approved by the Ethics Committee on Human Research of the First Affiliated Hospital of Nanjing Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"68"}}